• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大型观察性研究中健康相关生活质量数据的可转移性到临床实践中:将 PROSa 研究中的腹膜后肉瘤患者与 TARPS-WG 队列进行比较。

Transferability of Health-Related Quality of Life Data of Large Observational Studies to Clinical Practice: Comparing Retroperitoneal Sarcoma Patients from the PROSa Study to a TARPS-WG Cohort.

机构信息

Sarcoma Unit, Department of Surgery, University Medical Center Mannheim, Mannheim, Germany.

National Center for Tumor Diseases (NCT/UCC), Dresden, Germany.

出版信息

Oncol Res Treat. 2022;45(11):660-669. doi: 10.1159/000525288. Epub 2022 Jun 14.

DOI:10.1159/000525288
PMID:35700716
Abstract

INTRODUCTION

Health-related quality of life (HRQoL) is crucial for shared decision-making. The "Patient-Reported Outcome measures in Sarcoma" (PROSa) study evaluated HRQoL in general. We evaluated the transferability of PROSa data to clinical practice for the subgroup of retroperitoneal sarcoma (RPS).

METHODS

To obtain a PROSa-RPS cohort, we excluded patients with bone sarcomas and gastrointestinal stromal tumors from the complete PROSa cohort (n = 1,113), limited tumor localization to trunk and retroperitoneum, and excluded patients with metastases. We evaluated the HRQoL data of the resulting 76 patients and compared their clinical data to those of the Transatlantic Autralasian Retroperitoneal Sarcoma Working Group (TARPS-WG, n = 1,007).

RESULTS

Confidence intervals for patient sex, histological subtype (LPS vs. non-LPS), grading (G1 vs. G2/3), surgical margins (R2 vs. no R2), and perioperative chemo- and radiotherapy (yes vs. no) were overlapping in both cohorts. EORTC QLQ-C30 from RPS-PROSa patients demonstrated that two-thirds had clinically relevant restrictions in physical functioning. Two-thirds reported dyspnea, followed by fatigue and pain.

CONCLUSION

Clinical data from RPS-PROSa patients are comparable to those of an RPS reference cohort from expert centers. We believe that HRQoL data of RPS patients extracted from PROSa are transferable to clinical practice.

摘要

简介

健康相关生活质量(HRQoL)对于共同决策至关重要。“肉瘤患者报告结局测量”(PROSa)研究总体上评估了 HRQoL。我们评估了 PROSa 数据对包括腹膜后肉瘤(RPS)亚组在内的临床实践的可转移性。

方法

为了获得 PROSa-RPS 队列,我们从完整的 PROSa 队列(n=1113)中排除了骨肉瘤和胃肠道间质瘤患者,将肿瘤局限于躯干和腹膜后,排除了转移患者。我们评估了由此产生的 76 名患者的 HRQoL 数据,并将其临床数据与跨大西洋澳大拉西亚腹膜后肉瘤工作组(TARPS-WG,n=1007)的临床数据进行了比较。

结果

两组患者的性别、组织学亚型(低级别软组织肉瘤[LPS]与非 LPS)、分级(G1 与 G2/3)、手术切缘(R2 与无 R2)和围手术期化疗和放疗(是与否)的置信区间重叠。来自 RPS-PROSa 患者的 EORTC QLQ-C30 表明,三分之二的患者在身体功能方面存在临床相关的限制。三分之二的患者报告呼吸困难,其次是疲劳和疼痛。

结论

RPS-PROSa 患者的临床数据与专家中心的 RPS 参考队列相似。我们相信,从 PROSa 提取的 RPS 患者的 HRQoL 数据可转移到临床实践中。

相似文献

1
Transferability of Health-Related Quality of Life Data of Large Observational Studies to Clinical Practice: Comparing Retroperitoneal Sarcoma Patients from the PROSa Study to a TARPS-WG Cohort.大型观察性研究中健康相关生活质量数据的可转移性到临床实践中:将 PROSa 研究中的腹膜后肉瘤患者与 TARPS-WG 队列进行比较。
Oncol Res Treat. 2022;45(11):660-669. doi: 10.1159/000525288. Epub 2022 Jun 14.
2
Health related Quality of Life over time in German sarcoma patients. An analysis of associated factors - results of the PROSa study.德国肉瘤患者随时间变化的健康相关生活质量。相关因素分析 - PROSa 研究结果。
Front Endocrinol (Lausanne). 2023 Aug 29;14:1166838. doi: 10.3389/fendo.2023.1166838. eCollection 2023.
3
Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group.成人复发性腹膜后肉瘤(RPS)的管理:跨大西洋RPS工作组的共识方法。
Ann Surg Oncol. 2016 Oct;23(11):3531-3540. doi: 10.1245/s10434-016-5336-7. Epub 2016 Aug 1.
4
Long-term quality of life after resection of retroperitoneal soft tissue sarcoma.腹膜后软组织肉瘤切除术后的长期生活质量。
Eur J Surg Oncol. 2023 Nov;49(11):106977. doi: 10.1016/j.ejso.2023.07.003. Epub 2023 Jul 4.
5
Does palliative chemotherapy really palliate and are we measuring it correctly? A mixed methods longitudinal study of health related quality of life in advanced soft tissue sarcoma.姑息化疗真的能缓解症状吗?我们的测量方法正确吗?一项关于晚期软组织肉瘤患者健康相关生活质量的混合方法纵向研究。
PLoS One. 2019 Sep 26;14(9):e0210731. doi: 10.1371/journal.pone.0210731. eCollection 2019.
6
The association of Health-Related Quality of Life and 1-year-survival in sarcoma patients-results of a Nationwide Observational Study (PROSa).肉瘤患者健康相关生活质量与 1 年生存率的相关性——一项全国性观察研究(PROSa)的结果。
Br J Cancer. 2022 May;126(9):1346-1354. doi: 10.1038/s41416-022-01702-z. Epub 2022 Jan 20.
7
Management of primary retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group.成人原发性腹膜后肉瘤(RPS)的管理:跨大西洋RPS工作组的共识方法。
Ann Surg Oncol. 2015 Jan;22(1):256-63. doi: 10.1245/s10434-014-3965-2. Epub 2014 Oct 15.
8
Major vascular reconstruction in colorectal adenocarcinoma and retroperitoneal sarcoma: A retrospective study of safety and margins in a tertiary referral centre.结直肠癌和腹膜后肉瘤的主要血管重建:三级转诊中心安全性和切缘的回顾性研究。
Surg Oncol. 2022 Dec;45:101871. doi: 10.1016/j.suronc.2022.101871. Epub 2022 Oct 7.
9
Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group.成人局部复发性腹膜后肉瘤的治疗:来自跨大西洋澳大拉西亚腹膜后肉瘤工作组的最新共识方法。
Ann Surg Oncol. 2022 Nov;29(12):7335-7348. doi: 10.1245/s10434-022-11864-y. Epub 2022 Jun 29.
10
Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma.低容量医院的治疗与腹膜后肉瘤患者的短期和长期预后降低有关。
Cancer. 2018 Dec 1;124(23):4495-4503. doi: 10.1002/cncr.31699. Epub 2018 Oct 14.

引用本文的文献

1
Twenty-five years of experience with patient-reported outcome measures in soft-tissue sarcoma patients: a systematic review.软组织肉瘤患者报告结局测量 25 年的经验:系统评价。
Qual Life Res. 2024 Dec;33(12):3189-3211. doi: 10.1007/s11136-024-03755-4. Epub 2024 Sep 11.